Effect of RNAi Against 53BP1 Gene on Radiosensitivity of Human Esophageal Carcinoma ECA109 Cell

Abstract

months and the median system metastases from 8.8 months to 14.5 months. While systemic metastases increased from 21.6% to 30.4% (p Z 0.032) by postoperative IMRT treatment. Conclusions: Postoperative IMRT reduced local recurrence and improved survival for patients with lymph node positive or stage III TESCC, which would provide rationale in establishing patient selection criteria for the postoperative IMRT for TESCC after surgery. Author Disclosure: W. Zhang: None. Z. Xiao: None. X. Liu: None. D. Chen: None. Q. Feng: None. Z. Zhou: None. H. Zhang: None. L. Wang: None. J. He: None.